|Articles|August 1, 2003

Targeting Melanoma

Chicago - Targeted drug therapy, a rational approach to the treatment of malignant melanoma, offers a number of targeted agents currently in development, according to Scott Saxman, M.D., senior investigator, Cancer Therapy Evaluation Program, National Cancer Institute.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME